0001209191-14-009833.txt : 20140212 0001209191-14-009833.hdr.sgml : 20140212 20140212180034 ACCESSION NUMBER: 0001209191-14-009833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140212 FILED AS OF DATE: 20140212 DATE AS OF CHANGE: 20140212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Public Joint Stock Co Pharmstandard CENTRAL INDEX KEY: 0001598754 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 14601837 BUSINESS ADDRESS: STREET 1: LIKHACHEVSKY DRIVE STREET 2: 5 "B" CITY: DOLGOPRUDNY STATE: 1Z ZIP: 141701 BUSINESS PHONE: 7 495 970 0032 MAIL ADDRESS: STREET 1: LIKHACHEVSKY DRIVE STREET 2: 5 "B" CITY: DOLGOPRUDNY STATE: 1Z ZIP: 141701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pharmstandard International S.A. CENTRAL INDEX KEY: 0001598762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 14601838 BUSINESS ADDRESS: STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE CITY: LUXEMBOURG STATE: N4 ZIP: L-1528 BUSINESS PHONE: 352 26449 557 MAIL ADDRESS: STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE CITY: LUXEMBOURG STATE: N4 ZIP: L-1528 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-02-12 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001598762 Pharmstandard International S.A. 65, BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1331 LUXEMBOURG 0 0 1 0 0001598754 Public Joint Stock Co Pharmstandard LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 1417000 RUSSIAN FEDERATION 0 0 1 0 Common Stock 2014-02-12 4 C 0 4708549 A 4708549 I See footnote Common Stock 2014-02-12 4 P 0 1275000 8.00 A 5983549 I See footnote Series E Preferred Stock 2014-02-12 4 C 0 4708549 0.00 D Common Stock 4708549 0 I See footnote Each share of Series E Preferred Stock converted into 0.1667 shares of common stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The Series E Preferred Stock has no expiration date. Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company "Pharmsandard". As the parent entity, Public Joint Stock Company "Pharmstandard" has voting and investment power over the shares of the Issuer held by Pharmstandard International S.A. /s/ Gerard Birchen 2014-02-12 /s/ Eriks Martinovskis 2014-02-12